BACKGROUND: Tetracyclines such as doxycycline are reported to possess cytotoxic activity against mammalian tumor cells, but the mechanism of their effects on cell proliferation remains unclear. MATERIALS AND METHODS: The antitumor effect of doxycycline was investigated in human pancreatic cancer cell line, PANC-1. We also investigated the effect of doxycycline on expression of a potent proangiogenic factor, interleukin (IL)-8. RESULTS: In excess of 20 microg/ml, cytotoxic effects of doxycycline were accompanied by G(1)-S cell cycle arrest and DNA fragmentation in PANC-1 cells. Doxycycline consistently activated transcription of p53, p21 and Fas/FasL-cascade-related genes, while reducing the expression of Bcl-xL and Mcl-1. Doxycycline (5 microg/ml) below the cytotoxic level suppressed endogenous and paclitaxel-induced IL-8 expression. In the mouse xenograft model, doxycycline treatment was shown to suppress tumor growth by 80%. CONCLUSION: These data suggest that doxycycline exerts its antitumor effect by activating proapoptotic genes, inhibiting IL-8 expression, and suppressing antiapoptotic genes.
BACKGROUND:Tetracyclines such as doxycycline are reported to possess cytotoxic activity against mammaliantumor cells, but the mechanism of their effects on cell proliferation remains unclear. MATERIALS AND METHODS: The antitumor effect of doxycycline was investigated in humanpancreatic cancer cell line, PANC-1. We also investigated the effect of doxycycline on expression of a potent proangiogenic factor, interleukin (IL)-8. RESULTS: In excess of 20 microg/ml, cytotoxic effects of doxycycline were accompanied by G(1)-S cell cycle arrest and DNA fragmentation in PANC-1 cells. Doxycycline consistently activated transcription of p53, p21 and Fas/FasL-cascade-related genes, while reducing the expression of Bcl-xL and Mcl-1. Doxycycline (5 microg/ml) below the cytotoxic level suppressed endogenous and paclitaxel-induced IL-8 expression. In the mouse xenograft model, doxycycline treatment was shown to suppress tumor growth by 80%. CONCLUSION: These data suggest that doxycycline exerts its antitumor effect by activating proapoptotic genes, inhibiting IL-8 expression, and suppressing antiapoptotic genes.
Authors: Liboria Siena; Elisabetta Pace; Maria Ferraro; Caterina Di Sano; Mario Melis; Mirella Profita; Mario Spatafora; Mark Gjomarkaj Journal: Immunology Date: 2014-02 Impact factor: 7.397
Authors: Matthew T Basel; Sivasai Balivada; Tej B Shrestha; Gwi-Moon Seo; Marla M Pyle; Masaaki Tamura; Stefan H Bossmann; Deryl L Troyer Journal: Small Date: 2012-01-11 Impact factor: 13.281
Authors: Ryuta Tobe; Salvador Naranjo-Suarez; Robert A Everley; Bradley A Carlson; Anton A Turanov; Petra A Tsuji; Min-Hyuk Yoo; Steven P Gygi; Vadim N Gladyshev; Dolph L Hatfield Journal: J Biol Chem Date: 2013-04-15 Impact factor: 5.157
Authors: Ethan Ahler; William J Sullivan; Ashley Cass; Daniel Braas; Autumn G York; Steven J Bensinger; Thomas G Graeber; Heather R Christofk Journal: PLoS One Date: 2013-05-31 Impact factor: 3.240
Authors: Roberta Di Caprio; Serena Lembo; Luisa Di Costanzo; Anna Balato; Giuseppe Monfrecola Journal: Mediators Inflamm Date: 2015-04-22 Impact factor: 4.711
Authors: Rebecca Lamb; Bela Ozsvari; Camilla L Lisanti; Herbert B Tanowitz; Anthony Howell; Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti Journal: Oncotarget Date: 2015-03-10